Neuromodulation for Internal Organs
Part of Invention, Investment, and Invigoration (i3): Serving the Patient
Details
- Date
- Thursday, January 21, 2027
- Time
- 11:15 AM – 12:00 PM
- Session type
- Pre-Conference Session
- Schedule
- See this day
About
This full-day pre-conference course will provide a comprehensive overview of the evolving neuromodulation ecosystem, organized around the central theme of serving the patient. Bringing together leaders from academia, industry, and investment, the program will explore the field from technological innovation through commercialization and clinical adoption. Sessions will examine the future of neuromodulation, the funding outlook for emerging startups, and advances in key areas including brain-computer interfaces, neuromodulation for internal organs, and emerging modalities such as ultrasound-based stimulation. Additional discussion will address the critical role of reimbursement and evidence generation in ensuring patient access to new therapies. The course will conclude with a panel featuring senior leaders from major neuromodulation companies sharing perspectives on industry trends and future opportunities. Designed to encourage cross-sector dialogue, the program aims to highlight how scientific, clinical, and business decisions ultimately converge around a common goal: improving outcomes and access for patients.
Presenters
-
Victor Pikov is a CEO at Medipace Inc and a Vice President of Product Development at Transtimulation Research, two medical device companies developing implantable and wearable neuromodulation therapies for gastrointestinal diseases. Our device for treating irritable bowel syndrome has the FDA clearance, while other devices for treating inflammatory bowel disease, constipation, and functional dyspepsia are undergoing clinical studies. Victor previously worked at Galvani Bioelectronics and GlaxoSmithKline, co-leading the development of implantable neuromodulation devices for autoimmune and metabolic diseases, infertility, and overactive bladder. At the Huntington Medical Research Institutes, Victor developed implantable and wearable devices for chronic diseases, such as infertility, bladder paralysis, obstructive sleep apnea, and hearing loss. During post-doctoral work at California Institute of Technology, Victor developed optogenetic and radiofrequency methods of neuronal stimulation, including a microwave technology for non-invasive glucose measurement.
-
